Concepedia

James E. Herndon

JE

4

Publications

436

Citations

4

H-Index

1992

Active since

Affiliations

Duke University Hospital(Current)

Duke Medical Center

Duke University

James E. Herndon is an author at Duke University Hospital specializing in medicine, pharmacotherapy, and cancer therapeutics.

Top concepts

Publications per year

1992–2000

4

Publications

4

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

H. S. Friedman, Demetrius M. Kokkinakis, James M. Pluda et al. · Journal of Clinical Oncology · 1998 · 216 citations

Quality of life for adult leukemia survivors treated on clinical trials of cancer and leukemia group B during the period 1971-1988

Alice B. Kornblith, James E. Herndon, Enid Zuckerman et al. · Cancer · 1997 · 126 citations

Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy

Gamal Akabani, Ilkcan Cokgor, Robert E. Coleman et al. · International Journal of Radiation Oncology*Biology*Physics · 2000 · 69 citations

, , +8

Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trial.

Timothy J. Panella, David C. Smith, S. Clifford Schold et al. · PubMed · 1992 · 25 citations

, , +13

Rows per page

1–4 of 4